Synovial Sarcoma of Foot
Synovial Sarcoma of Foot
Clinical Scenario
A 15-year-old male presents with a slowly enlarging lump on the lateral border of his right foot that he first noticed 6 months ago. It has been gradually increasing in size and has recently become mildly painful. He is otherwise fit and well with no significant medical history.
History:
- 6-month history of painless lump, now mildly tender
- No history of trauma
- Gradual increase in size (initially marble-sized, now golf ball-sized)
- No constitutional symptoms (no weight loss, night sweats, fevers)
- No previous skin lesions or radiation exposure
- No family history of malignancy
- Full-time student, plays football recreationally
Examination Findings:
- 4 x 3 cm firm, non-fluctuant mass on lateral border of right foot
- Located over 5th metatarsal region
- Not attached to skin, moves slightly with underlying tissues
- Non-tender to palpation
- No overlying skin changes
- No palpable regional lymphadenopathy (inguinal nodes)
- Full range of motion of ankle and foot
- Normal neurovascular examination distally
- Contralateral foot normal
Investigations
Laboratory Results
Imaging
Plain X-ray Right Foot:
- Soft tissue mass visible adjacent to 5th metatarsal
- Calcification within the mass (~30% of synovial sarcomas show calcification)
- No bone destruction or periosteal reaction
- No obvious bone involvement
MRI Right Foot with Gadolinium:
- 4.2 x 3.1 x 2.8 cm heterogeneous soft tissue mass
- Located in subcutaneous tissue adjacent to 5th metatarsal
- T1: Intermediate signal, iso-intense to muscle
- T2: Heterogeneous high signal with areas of low signal ("triple sign" or "bowl of grapes" appearance)
- Gadolinium: Heterogeneous enhancement
- Well-defined margins but no true capsule
- Abuts the 5th metatarsal periosteum but no cortical invasion
- Displaces but does not encase lateral plantar neurovascular bundle
- No skip lesions
CT Chest (Staging):
- No pulmonary metastases
- No mediastinal lymphadenopathy
Histopathology
Core Needle Biopsy Result:
- Biphasic synovial sarcoma
- Epithelial and spindle cell components present
- Immunohistochemistry: CK7+, EMA+, bcl-2+, TLE1+
- FISH positive for SYT-SSX translocation t(X;18)
- Grade: High grade (FNCLCC Grade 3)
Questions & Model Answers
What is your differential diagnosis for a soft tissue mass in the foot of an adolescent, and what features suggest synovial sarcoma?
Describe the appropriate biopsy technique for this suspected soft tissue sarcoma.
This is confirmed as synovial sarcoma. What is the pathognomonic genetic finding and how is synovial sarcoma staged?
What are the surgical options for this patient and what factors influence limb salvage versus amputation?
What is the role of adjuvant therapy in synovial sarcoma?
What is the prognosis and follow-up protocol for this patient?
Key Teaching Points
| Concept | Detail |
|---|---|
| Age Group | Most common STS in adolescents/young adults |
| Genetic Marker | t(X;18) SYT-SSX translocation is pathognomonic |
| Misnomer | Does NOT arise from synovium despite name |
| Calcification | 30% show calcification on X-ray (rare in other STS) |
| Chemosensitive | More responsive to chemo than most STS |
| Biopsy | By treating surgeon, longitudinal, tract excisable |
| Surgery | Wide margins (>1cm); ray amputation often sufficient in foot |
Common Examiner Follow-up Questions
-
"What is clear cell sarcoma and why is it important in the foot?"
- Also called "melanoma of soft parts"
- Involves tendons and aponeuroses
- Predilection for foot and ankle
- S100 positive, HMB45 positive (like melanoma)
- Has EWSR1-ATF1 translocation
- Highly aggressive, poor prognosis
-
"What are Mankin's principles of biopsy?"
- Study showed 3x higher error rate at referring hospitals
- Biopsy by treating surgeon
- Longitudinal incision
- Through muscle not between compartments
- Track must be excisable
- Avoid haematoma
-
"What is the FNCLCC grading system?"
- French grading system for soft tissue sarcomas
- Based on: Differentiation, Mitotic count, Necrosis
- Grade 1 (low), Grade 2 (intermediate), Grade 3 (high)
- Predicts metastatic risk